Cargando…
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC
EZH2 is a negative prognostic factor and is overexpressed or activated in most human cancers including head and neck squamous cell carcinoma (HNSCC). Analysis of The Cancer Genome Atlas (TCGA) HNSCC data indicated that EZH2 over-expression was associated with high tumor grade and conferred poor prog...
Autores principales: | Zhou, Xuan, Ren, Yu, Kong, Lingping, Cai, Guoshuai, Sun, Shanshan, Song, Wangzhao, Wang, Yu, Jin, Rui, Qi, Lisha, Mei, Mei, Wang, Xudong, Kang, Chunsheng, Li, Min, Zhang, Lun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741797/ https://www.ncbi.nlm.nih.gov/pubmed/26378043 |
Ejemplares similares
-
PD-L2 based immune signature confers poor prognosis in HNSCC
por: Qiao, Yu, et al.
Publicado: (2021) -
Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
por: Zhou, Xuan, et al.
Publicado: (2015) -
Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2018) -
Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2023) -
WP1066 Sensitizes Oral Squamous Cell Carcinoma Cells to Cisplatin by Targeting STAT3/miR-21 axis
por: Zhou, Xuan, et al.
Publicado: (2014)